SCHEMBL7804294

SCHEMBL7804294

CC(C)OC(=O)C(C)(C)Oc1cccc(C2=CCN(C(=O)c3cc(I)c(O)c(I)c3)CC2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.39
ALDH1A1 P00352 2/20 0.39
NAMPT P43490 3/20 0.39
POLB P06746 1/20 0.39
ALOX15 P16050 1/20 0.39
PPARG P37231 2/20 0.38
PPARA Q07869 2/20 0.38
MMP2 P08253 2/20 0.36
MMP3 P08254 1/20 0.36
KCNH2 Q12809 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
QDPR P09417 2/20 0.36
TDP1 Q9NUW8 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MAPT P10636 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
USP2 O75604 1/20 0.35
ABCB11 O95342 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7813597 0.90 HPGD (0.39) HPGDALDH1A1NAMPTPOLBALOX15
SCHEMBL7809885 0.90 POLB (0.41) HPGDALDH1A1NAMPTPOLBALOX15
SCHEMBL7813905 0.89 ALDH1A1 (0.46) HPGDALDH1A1NAMPTPOLBALOX15
SCHEMBL7804444 0.88 NAMPT (0.44) HPGDALDH1A1NAMPTPOLBALOX15
SCHEMBL7810085 0.88 PPARG (0.48) HPGDALDH1A1NAMPTPOLBALOX15
SCHEMBL7817469 0.88 NAMPT (0.44) HPGDALDH1A1NAMPTPOLBALOX15
SCHEMBL7817528 0.87 NAMPT (0.49) HPGDALDH1A1NAMPTPOLBALOX15
SCHEMBL7811486 0.87 PPARG (0.49) HPGDALDH1A1NAMPTPOLBALOX15
SCHEMBL7814015 0.87 NAMPT (0.44) HPGDALDH1A1NAMPTPOLBALOX15
SCHEMBL7813624 0.85 POLB (0.40) HPGDALDH1A1NAMPTPOLBALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607536-B1 Arylamide derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed